Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Sep;38(9):2024–2028. doi: 10.1128/aac.38.9.2024

Ticarcillin-clavulanic acid pharmacokinetics in preterm neonates with presumed sepsis.

A H Burstein 1, L E Wyble 1, P Gal 1, P R Diaz 1, J L Ransom 1, R Q Carlos 1, A Forrest 1
PMCID: PMC284678  PMID: 7811013

Abstract

The objective of the reported study was to characterize the pharmacokinetics of ticarcillin and clavulanic acid in premature low-birth-weight (less than 2,200 g) neonates with presumed sepsis. Eleven infants received 12 courses of ticarcillin-clavulanic acid at 75 mg/kg of body weight intravenously every 12 h. Blood samples were collected at 0.5, 1.5, 4, and 8 h following the infusion of the initial dose. The concentrations of ticarcillin and clavulanic acid were determined by a microbiologic assay. Median (interpatient coefficients of variation) values for the volume of the central compartment, total steady-state volume, distributional clearance, total clearance, and terminal elimination half-life for ticarcillin were 0.030 liter/kg (21%), 0.26 liter/kg (48%), 0.41 liter/h/kg (47%), 0.047 liter/h/kg (47%), and 4.2 h (45%), respectively. For clavulanic acid the parameters were 0.28 liter/kg (32%), 0.36 liter/kg (34%), 11 liters/h/kg (36%), 0.12 liters/h/kg (72%), and 1.95 h (40%), respectively. Our results suggest that the current dosing recommendations of 75 mg/kg every 12 h risk subtherapeutic clavulanic acid concentrations and that 50 mg/kg every 6 h is a more rational dosing strategy.

Full text

PDF
2024

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assael B. M. Pharmacokinetics and drug distribution during postnatal development. Pharmacol Ther. 1982;18(2):159–197. doi: 10.1016/0163-7258(82)90066-3. [DOI] [PubMed] [Google Scholar]
  2. Ballard J. L., Novak K. K., Driver M. A simplified score for assessment of fetal maturation of newly born infants. J Pediatr. 1979 Nov;95(5 Pt 1):769–774. doi: 10.1016/s0022-3476(79)80734-9. [DOI] [PubMed] [Google Scholar]
  3. Bush K., Macalintal C., Rasmussen B. A., Lee V. J., Yang Y. Kinetic interactions of tazobactam with beta-lactamases from all major structural classes. Antimicrob Agents Chemother. 1993 Apr;37(4):851–858. doi: 10.1128/aac.37.4.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. D'Argenio D. Z. Optimal sampling times for pharmacokinetic experiments. J Pharmacokinet Biopharm. 1981 Dec;9(6):739–756. doi: 10.1007/BF01070904. [DOI] [PubMed] [Google Scholar]
  5. Davies B. E., Coates P. E., Clarke J. G., Thawley A. R., Sutton J. A. Bioavailability and pharmacokinetics of clavulanic acid in healthy subjects. Int J Clin Pharmacol Ther Toxicol. 1985 Feb;23(2):70–73. [PubMed] [Google Scholar]
  6. Drusano G. L., Forrest A., Snyder M. J., Reed M. D., Blumer J. L. An evaluation of optimal sampling strategy and adaptive study design. Clin Pharmacol Ther. 1988 Aug;44(2):232–238. doi: 10.1038/clpt.1988.142. [DOI] [PubMed] [Google Scholar]
  7. Fayed S. B., Sutton A. M., Turner T. L., McAllister T. A. The prophylactic use of ticarcillin/clavulanate in the neonate. J Antimicrob Chemother. 1987 Jan;19(1):113–118. doi: 10.1093/jac/19.1.113. [DOI] [PubMed] [Google Scholar]
  8. Fisher J., Charnas R. L., Knowles J. R. Kinetic studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid. Biochemistry. 1978 May 30;17(11):2180–2184. doi: 10.1021/bi00604a024. [DOI] [PubMed] [Google Scholar]
  9. Forrest A., Ballow C. H., Nix D. E., Birmingham M. C., Schentag J. J. Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin. Antimicrob Agents Chemother. 1993 May;37(5):1065–1072. doi: 10.1128/aac.37.5.1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fricke G., Doerck M., Hafner D., Horton R., Kresken M. The pharmacokinetics of ticarcillin/clavulanate acid in neonates. J Antimicrob Chemother. 1989 Nov;24 (Suppl B):111–120. doi: 10.1093/jac/24.suppl_b.111. [DOI] [PubMed] [Google Scholar]
  11. Prober C. G., Stevenson D. K., Benitz W. E. The use of antibiotics in neonates weighing less than 1200 grams. Pediatr Infect Dis J. 1990 Feb;9(2):111–121. doi: 10.1097/00006454-199002000-00009. [DOI] [PubMed] [Google Scholar]
  12. Staniforth D. H., Coates P. E., Davies B. E., Horton R. Pharmacokinetics of parenteral ticarcillin formulated with clavulanic acid: Timentin. Int J Clin Pharmacol Ther Toxicol. 1986 Mar;24(3):123–129. [PubMed] [Google Scholar]
  13. Sutherland R., Beale A. S., Boon R. J., Griffin K. E., Slocombe B., Stokes D. H., White A. R. Antibacterial activity of ticarcillin in the presence of clavulanate potassium. Am J Med. 1985 Nov 29;79(5B):13–24. doi: 10.1016/0002-9343(85)90124-x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES